What is the recommended administration route, dosage, and contraindications for Influvac Tetra (influenza vaccine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Influvac Tetra Administration

Influvac Tetra should be administered intramuscularly at a dose of 0.5 mL for all individuals aged 6 months and older, with the deltoid muscle preferred for adults and older children, and the anterolateral thigh for infants and young children 1.

Route and Dosage

  • Route: Intramuscular (IM) injection only
  • Dose volume: 0.5 mL per dose for all age groups ≥6 months 1
  • Injection site:
    • Adults and older children: deltoid muscle
    • Infants and young children: anterolateral aspect of the thigh 2, 3

Number of Doses Required

The dosing schedule depends on the child's age and vaccination history:

Children aged 6 months through 8 years:

  • 1 dose if they have previously received ≥2 doses of trivalent or quadrivalent influenza vaccine ≥4 weeks apart before the current season (doses do not need to be from the same or consecutive seasons) 2, 3
  • 2 doses (≥4 weeks apart) if they have not received ≥2 previous doses or vaccination history is unknown 2, 3

All persons aged ≥9 years:

  • 1 dose annually 2

Contraindications

Absolute contraindications include 3:

  • History of severe allergic reaction (e.g., anaphylaxis) to any component of the vaccine
  • History of severe allergic reaction to a previous dose of any influenza vaccine (egg-based IIV, ccIIV, RIV, or LAIV)

Important note on egg allergy: While a history of severe allergic reaction to egg is a labeled contraindication for egg-based vaccines, ACIP recommends that all persons aged ≥6 months with egg allergy should receive influenza vaccine, and any influenza vaccine (egg-based or non-egg based) that is otherwise appropriate can be used 2, 3.

Precautions

Vaccination should be deferred or carefully considered in 3:

  • Moderate or severe acute illness with or without fever
  • History of Guillain-Barré syndrome within 6 weeks of receipt of influenza vaccine

Common Pitfalls to Avoid

  1. Dose volume confusion: Unlike some other influenza vaccines (Afluria, Fluzone) that have 0.25 mL doses for children aged 6-35 months, Influvac Tetra uses 0.5 mL for all ages 1

  2. Two-dose requirement: Children aged 6 months through 8 years who are receiving influenza vaccine for the first time or have not received ≥2 previous doses need 2 doses—missing the second dose leaves them inadequately protected 2, 3

  3. Timing: Vaccination should occur as soon as vaccine becomes available in the season, without delay 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.